Search results
Teddi Mellencamp Thought She Was in Menopause but It Was 'Symptoms from the Copper IUD'
People Magazine· 4 days agoOn April 30, the Real Housewives of Beverly Hills alum posted a video on Instagram asking her...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 48 minutes agoTAR-210 results show 90% recurrence-free survival and 90% complete response in patients with high-risk and intermediate-risk non-muscle-invasive bladder cancer, respectively ...
Paul F. deLespinasse: Supreme Court's Hobby Lobby decision was based on economic confusion
The Daily Telegram via Yahoo News· 4 days agoThe challenges to the contraception requirement in the Affordable Care Act — Obamacare — were based...
Red Cross to laud women from Chicago Heights, Dolton, who have made a habit of helping
Chicago Tribune· 15 hours agoBack when Chez Smith was an administrator at Cook County’s Fantus Clinic near Stroger Hospital in...
Opinion | Where’s Josh Shapiro’s Pragmatism When You Need It?
The Wall Street Journal· 8 hours agoIt was nowhere to be found in his treatment of the Little Sisters of the Poor.
After Roe, the network of people who help others get abortions see themselves as ‘the underground’
FOX 4 Kansas City· 1 day agoNAMPA, Idaho (AP) — Waiting in a long post office line with the latest shipment of “abortion...
After Roe, an Abortion 'Underground' Emerges
newser· 1 day ago"This is the underground," said Jerad Martindale, an activist in Boise. Abortion rights advocates worry Idaho is a harbinger of where more states may be...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
WTNH-TV New Haven· 2 days agoFollowing RP, patients who received the treatment regimen showed a 100% biochemical recurrence...
Cwm LLC Acquires 1,087 Shares of Organon & Co. (NYSE:OGN)
ETF DAILY NEWS· 20 hours agoCwm LLC raised its holdings in shares of Organon & Co. (NYSE:OGN – Free Report) by 8.3% in the fourth quarter, according to the company in its most recent Form 13F filing ...
...Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-...
The Tomahawk· 4 days agoA comment in the same issue discussed implications of the data and recognized microarray technology for its potential to be "game-changing in humanitarian settings." In the same issue, the needle ...